TEV-56286 not checked
Teva Branded Pharmaceutical Products R&D LLC · anle138b
FollowEvery change as it happens, and a Monday email
Trials
3 active
5 in total · 3 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Multiple System Atrophy (2 trials)
- Main trialPhase 2
- “The primary objective of the study is to evaluate the efficacy of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the study is to evaluate specific efficacy parameters of TEV-56286. Another secondary objective is to evaluate the safety and tolerability of TEV-56286. The planned study period per participant is 56 weeks including a screening period (up to 4 weeks), a 48-week double-blind treatment period, and a follow-up visit (approximately 4 weeks after the end of the double-blind treatment period). The…”In the company’s words, NCT06568237 on ClinicalTrials.gov
- Other names
- emrusolmin · anle138b
Other drugs for Multiple System Atrophy
Coming up3
- 15 Jan 2027Phase 1 trial completes · ClinicalTrials.gov
- 15 Sep 2027Phase 2 trial completes · ClinicalTrials.gov
- 3 May 2029Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Active, not recruiting | 15 Sep 2027 | A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy | |
| Phase 2Recruiting | 3 May 2029 | An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy | |
| Phase 1Recruiting | 15 Jan 2027 | A Trial to Assess TEV-56286 at Different Doses in Healthy Participants | |
| Phase 1Completed | 29 Nov 2024 | Mass Balance Clinical Trial With TEV-56286 | |
| Phase 1Completed | 22 May 2025 | A Study to Assess New Formulations of TEV-56286 |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026